critical evaluation on covid-19
Answers
Answered by
0
Highlights
•
Dexamethasone reduces the risk of death in patients critically ill with COVID-19.
•
No evidence of benefit from other complementary and/or supportive treatments was seen in critically ill COVID-19 hospitalized patients.
•
Synthetic glucocorticoids switch off cytokine storm, and consequent severe respiratory and multi-organ failures in patients with COVID-19.
•
Effects of synthetic glucocorticoids might be confounded by the contemporary use of other complementary drugs.
I hope this will help you thank me and make me brainliest please
Similar questions